HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-02Clinical Trial Update: A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes [NA]
This is a completed clinical trial sponsored by Bristol-Myers Squibb evaluating nystatin for prevention of oral candidiasis in patients with…
-
CLINICAL_TRIALS trial_result · 2007-10-01Clinical Trial Update: Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers
A completed clinical trial investigating nevirapine resistance among HIV-infected mothers.
-
CLINICAL_TRIALS trial_result · 2007-09-27Clinical Trial Update: Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects [Phase 2]
A Phase 2 study assessing metabolic toxicities of combining Lopinavir/ritonavir with Saquinavir mesylate or Lamivudine/Zidovudine in HIV-inf…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Antihyperlipidemic Effects of Oyster Mushrooms [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a completed Phase 1/2 trial evaluating whether oyster mushrooms have antihyperlipidemic effects, spon…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers [Phase 1]
This is a Phase I comparative study evaluating the HIV vaccine candidate HIVAC-1e against a Smallpox (Vaccinia) vaccine in volunteers with a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-09-25FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie. This action updates the product's labeling or ind…
-
FDA approval · 2007-09-25FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines [Phase 1]
A Phase 1 clinical trial by NIAID compares injection sites (groin vs arm) for administering HIV vaccines to determine the optimal administra…
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Tuberculosis in HIV Infected Patients in Uganda [Phase 2]
A Phase 2 trial evaluating tuberculosis treatment in HIV-infected individuals in Uganda has completed.
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Analysis of Immune Responses to HIV Vaccines
This report summarizes the immune responses elicited by HIV vaccines in a completed NIAID-sponsored clinical trial, detailing immunogenicity…
-
CLINICAL_TRIALS research · 2007-09-18Clinical Trial Update: Resistance to HIV Infection
Clinical trial update from NIAID pertaining to resistance to HIV infection; the current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Vitamin A Therapy for Tuberculosis [Phase 3]
Phase 3 clinical trial update reporting completion of Vitamin A therapy for tuberculosis; the trial targets pulmonary tuberculosis and HIV i…
-
CLINICAL_TRIALS trial_result · 2007-09-18Clinical Trial Update: Strategies for Delivering Anti-HIV Therapy in South Africa [NA]
This is a completed clinical trial update discussing strategies for delivering anti-HIV therapy in South Africa (NCT00080522), sponsored by …
-
CLINICAL_TRIALS trial_result · 2007-09-14Clinical Trial Update: Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy [Phase 2]
Phase 2 pilot study evaluating high-concentration capsaicin patches for painful HIV-associated neuropathy; the trial status is unknown.
-
CLINICAL_TRIALS research · 2007-09-05Clinical Trial Update: RiSolubles™, the Soluble Fraction of Rice Bran for HIV-Infected Patients [Phase 2]
Clinical trial update on RiSolubles™, the soluble fraction of rice bran, for HIV infection in a Phase 2 study.
-
CLINICAL_TRIALS trial_result · 2007-08-30Clinical Trial Update: Long-Term Supervised Treatment Interruption in HIV-Infected Patients [Phase 3]
This Phase 3 clinical trial update reports on long-term supervised treatment interruption in HIV-infected patients; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2007-08-27Clinical Trial Update: HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs [Phase 1]
Phase 1 clinical trial of an HIV vaccine designed for HIV-infected adults on antiretroviral therapy has completed, assessing safety and immu…
-
CLINICAL_TRIALS trial_result · 2007-08-27Clinical Trial Update: Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating the safety and immune response of an HIV vaccine in healthy ad…
-
CLINICAL_TRIALS trial_result · 2007-08-27Clinical Trial Update: Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients [Phase 1]
Phase 1 clinical trial update on a therapeutic HIV vaccine given before a planned treatment interruption in HIV-infected patients. The study…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Male Circumcision for HIV Prevention in Rakai, Uganda [Phase 3]
Phase 3 randomized trial evaluating male circumcision for HIV prevention in Rakai, Uganda has completed.
-
CLINICAL_TRIALS research · 2007-08-16Clinical Trial Update: A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir) [NA]
Clinical trial update for a treatment IND protocol using didanosine (Videx) in AIDS/ARC patients intolerant to zidovudine, completed.
-
CLINICAL_TRIALS trial_result · 2007-08-10Clinical Trial Update: Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community [Phase 3]
A Phase 3 clinical trial update on the effects of male circumcision on HIV, sexually transmitted infections, and related behaviors in men, w…
-
FDA approval · 2007-08-06FDA Approved: SELZENTRY — Original Application (ViiV Healthcare Company)
FDA approval of Selzentry (maraviroc) by ViiV Healthcare as the original NDA, for treatment of CCR5-tropic HIV-1 infection in adults and cer…
-
FDA approval · 2007-07-31FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
The FDA approved a supplemental application for Viracept (nelfinavir mesylate) from Agouron Pharmaceuticals.
-
FDA approval · 2007-07-31FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
The FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron.